Treatment with escitalopram reduced serum P1NP by 1.02 ng/mL on average [ 95 % confidence interval ( CI ) -5.17 , 3.12 ] compared with a reduction of 1.88 ng/mL ( 95 % CI -4.82 , 1.06 ) in the placebo group ( P = .65 ) .